FLT3 and acute myeloid leukemia: Pre-existing mutations in the CCND3 gene (encoding cyclin D3) have been described in patients with FLT3-ITD-positive AML who did not respond to the FLT3 inhibitor PLX3397 in an early clinical trial [74].